The Institute for Chemical Neuroscience

The iCNS focuses on unraveling the molecular mechanisms of psychiatric disorders. For some neurological brain diseases, such as Alzheimer’s disease and multiple sclerosis, it is fairly well understood what changes occur and where in the brain. However, for psychiatric disorders such as depression, schizophrenia, or anxiety disorders, this is largely unknown. Within the iCNS, neurobiologists, chemists, psychiatrists, data scientists, and patient representatives work closely together to drive breakthroughs in research on psychiatric symptoms.